Evidence generation strategies for enhanced market access success

Evidence generation strategies for enhanced market access success

Unleashing the power of RWE for life sciences companies

Ensuring market access for a cutting-edge medical device, bio-pharmaceutical agent or diagnostic test is crucial for the long-term viability of life sciences organizations. Industry leaders aspiring to expand their market access reach need to understand the factors associated with securing coverage from payers and providers, especially for multinational companies or organizations looking to expand into global markets. As the industry proceeds to embrace the need for real-world evidence (RWE), there is a rising demand for life sciences organizations to gain a competitive advantage by leveraging RWE beyond clinical trials. However, understanding when to leverage RWE and how to integrate it into the product life cycle can expedite your market access success. 

Join Baker Tilly for an informative webinar discussing the importance of evidence generation for successful market access. In addition to discussing key considerations when building your evidence-generation strategy, our specialists will talk about the need for evidence-generation beyond clinical trial data. We will cover the crucial role RWE plays in helping pharma and medical device organizations enter global markets. Our team will also discuss how you can amplify RWE to create positive return on investment (ROI) for your organization.  

Who should attend 
  • CEOs, presidents, CFOs, CIOs, COOs, vice presidents, market access, medical affairs, government affairs, health policy and other management professionals in life sciences organizations 
  • David Gregory, MPA, FACHE, Principal, Baker Tilly 
  • Arun Parekkat, Managing Director, Baker Tilly 
  • Grace Macalino, PH.D., M.P.H., Director, Baker Tilly 
  • Keith Needham, Senior Manager, Baker Tilly 
  • Peter Bannister, Romilly Life Sciences 
 Learning objectives 
  • Understand the importance of having an effective evidence generation strategy 
  • Identify various evidence generation strategies and ways in which RWE can assist in accelerating market access success for your product 
  • Recognize the criteria that payers and providers use to assess coverage and facilitate adoption in the U.S., Europe and global markets, and understand how RWE can play a pivotal role in meeting industry standards 
  • Analyze how your organization can utilize RWE to increase ROI. 

There are no prerequisites for this webinar, and advance preparation is not required. There is no cost to attend this webinar.  

A certificate of completion will be emailed to you four to six weeks after the event. 
Level: Basic 
CPE credit: One (1) hour total credit 
Field of study: Specialized Knowledge (SK) 

For more information regarding administrative policies such as complaint and refund policies, please email [email protected]


Baker Tilly is registered with the National Association of State Boards of Accountancy as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: nasbaregistry.org

Similar events


Charting a course through healthcare price transparency regulations


Accounting for growth: the advantage of outsourced financials


Why small capital projects should be in your audit plan


Navigating the basics of internal controls